Cellular uptake of the Clostridium perfringens binary iota-toxin

被引:74
作者
Blöcker, D
Behlke, J
Aktories, K
Barth, H
机构
[1] Univ Freiburg, Inst Expt & Klin Pharmakol & Toxikol, D-79104 Freiburg, Germany
[2] Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany
关键词
D O I
10.1128/IAI.69.5.2980-2987.2001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The binary iota-toxin is produced by Clostridium perfringens type E strains and consists of two separate proteins, the binding component iota b (98 kDa) and an actin-ADP-ribosylating enzyme component iota a (47 kDa), Iota b binds to the cell surface receptor and mediates the translocation of iota a into the cytosol. Here we studied the cellular uptake of iota-toxin into Vero cells. Bafilomycin A1, but not brefeldin A or nocodazole, inhibited the cytotoxic effects of iota-toxin, indicating that toxin is translocated from an endosomal compartment into the cytoplasm. Acidification (pH less than or equal to 5.0) of the extracellular medium enabled iota a to directly enter the cytosol in the presence of iota b, Activation by chymotrypsin induced oligomerization of iota b in solution. An average mass of 530 +/- 28 kDa for oligomers was determined by analytical ultracentrifugation, indicating heptamer formation. The entry of iota-toxin into polarized CaCo-2 cells was studied by measuring the decrease in transepithelial resistance after toxin treatment. Iota-toxin led to a significant decrease in resistance when it was applied to the basolateral surface of the cells but not following application to the epical surface, indicating a polarized localization of the iota-toxin receptor.
引用
收藏
页码:2980 / 2987
页数:8
相关论文
共 39 条
[11]   ISOLATION AND CHARACTERIZATION OF A CLOSTRIDIUM-BOTULINUM C2 TOXIN-RESISTANT CELL-LINE - EVIDENCE FOR POSSIBLE INVOLVEMENT OF THE CELLULAR C2II RECEPTOR IN GROWTH-REGULATION [J].
FRITZ, G ;
SCHROEDER, P ;
AKTORIES, K .
INFECTION AND IMMUNITY, 1995, 63 (06) :2334-2340
[12]   Clostridium perfringens iota-toxin requires activation of both binding and enzymatic components for cytopathic activity [J].
Gibert, M ;
Petit, L ;
Raffestin, S ;
Okabe, A ;
Popoff, MR .
INFECTION AND IMMUNITY, 2000, 68 (07) :3848-3853
[13]  
GRUENBERG J, 1989, ANNU REV CELL BIOL, V5, P453
[14]   Evolution and mechanism from structures of an ADP-ribosylating toxin and NAD complex [J].
Han, S ;
Craig, JA ;
Putnam, CD ;
Carozzi, NB ;
Tainer, JA .
NATURE STRUCTURAL BIOLOGY, 1999, 6 (10) :932-936
[15]   GOLGI-APPARATUS IN CHICK SKELETAL-MUSCLE - CHANGES IN ITS DISTRIBUTION DURING END PLATE DEVELOPMENT AND AFTER DENERVATION [J].
JASMIN, BJ ;
CARTAUD, J ;
BORNENS, M ;
CHANGEUX, JP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (18) :7218-7222
[16]   The gene for component-II of botulinum C2 toxin [J].
Kimura, K ;
Kubota, T ;
Ohishi, I ;
Isogai, E ;
Isogai, H ;
Fujii, N .
VETERINARY MICROBIOLOGY, 1998, 62 (01) :27-34
[17]   ANTHRAX TOXIN PROTECTIVE ANTIGEN IS ACTIVATED BY A CELL-SURFACE PROTEASE WITH THE SEQUENCE SPECIFICITY AND CATALYTIC PROPERTIES OF FURIN [J].
KLIMPEL, KR ;
MOLLOY, SS ;
THOMAS, G ;
LEPPLA, SH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (21) :10277-10281
[18]  
Leppla S. H., 1995, Bacterial toxins and virulence factors in disease., P543
[19]  
MADSHUS IH, 1991, J BIOL CHEM, V266, P17446
[20]   ADP-RIBOSYLATION OF ACTIN ISOFORMS BY CLOSTRIDIUM-BOTULINUM-C2 TOXIN AND CLOSTRIDIUM-PERFRINGENS-IOTA TOXIN [J].
MAUSS, S ;
CHAPONNIER, C ;
JUST, I ;
AKTORIES, K ;
GABBIANI, G .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1990, 194 (01) :237-241